Advanced Prostate Cancer
About Clinical Trials
elm•pc Clinical Trials
Helpful Links
Home
•
Contact Us
Do you have metastatic prostate cancer?
Now is the time to consider all of your options.
> READ MORE
elm•pc004 Research Study (Chemotherapy Naive for Metastatic Disease)
The elm•pc004 research study is seeking men who have been diagnosed with metastatic prostate cancer and have not received chemotherapy for metastatic disease. > LEARN MORE elm•pc005 Research Study (Post-Chemotherapy)
The elm•pc005 research study is seeking men who have been diagnosed with metastatic prostate cancer and have received chemotherapy. > LEARN MORE
The elm•pc004 research study is seeking men who have been diagnosed with metastatic prostate cancer and have not received chemotherapy for metastatic disease. > LEARN MORE elm•pc005 Research Study (Post-Chemotherapy)
The elm•pc005 research study is seeking men who have been diagnosed with metastatic prostate cancer and have received chemotherapy. > LEARN MORE
The elm•pc research studies will evaluate the safety and effectiveness of an investigational medicine, TAK-700, given with prednisone, and determine if it can lengthen the lives of men with metastatic prostate cancer, compared to prednisone alone.
See if you may be eligible
for the elm•pc research studies by taking the online eligibility assessment or calling 1-855-473-5672.
